A 72-year-old woman with a history of small-cell lung cancer (SCLC) on active chemotherapy presents with progressive lethargy, anorexia, and a single episode of vomiting over 3 days. She denies polydipsia or polyuria. On examination, she is alert but lethargic, blood pressure 118/76 mmHg (baseline 130/80), heart rate 88/min, and mucous membranes are moist. There is no peripheral edema. Laboratory findings: serum sodium 124 mEq/L, serum osmolality 258 mOsm/kg, urine osmolality 420 mOsm/kg, urine sodium 68 mEq/L, serum creatinine 0.9 mg/dL (baseline 1.0 mg/dL), TSH 2.1 mIU/L. What is the most appropriate initial management?

Explanation

## Diagnosis: SIADH in SCLC **Key Point:** This patient meets all diagnostic criteria for SIADH: hyponatremia (124 mEq/L), hypotonic serum osmolality (258 mOsm/kg), inappropriately concentrated urine (420 mOsm/kg), elevated urine sodium (68 mEq/L), euvolemia (normal BP, moist mucous membranes, no edema), normal renal and thyroid function, and no diuretic use. SCLC is the most common malignancy causing SIADH (10–15% of cases). ## Severity Assessment **High-Yield:** Hyponatremia severity is determined by both the absolute sodium level AND the acuity of onset. | Severity | Sodium Level | Acute (<48 hrs) | Chronic (>48 hrs) | |----------|--------------|-----------------|-------------------| | Mild | 130–135 mEq/L | Asymptomatic | Asymptomatic | | Moderate | 125–129 mEq/L | Nausea, headache | Mild symptoms | | Severe | <125 mEq/L | Seizures, coma | Lethargy, confusion | This patient has moderate hyponatremia with mild symptoms (lethargy, anorexia) and likely chronic onset (3-day history), indicating **asymptomatic or minimally symptomatic chronic hyponatremia**. ## Management Strategy ```mermaid flowchart TD A[SIADH diagnosed]:::outcome --> B{Symptomatic?}:::decision B -->|Severe symptoms<br/>Seizures, altered mental status| C[Hypertonic 3% saline<br/>1-2 mL/kg/hour]:::urgent B -->|Asymptomatic or<br/>mild symptoms| D{Acuity?}:::decision D -->|Acute onset<br/>< 48 hours| E[Fluid restriction<br/>+ monitor Na]:::action D -->|Chronic onset<br/>> 48 hours| F[Fluid restriction<br/>500-800 mL/day]:::action C --> G[Correct Na by 8-10 mEq/L<br/>per 24 hours]:::action F --> H[Monitor Na every 4-6 hrs<br/>then daily]:::action ``` **Clinical Pearl:** The risk of osmotic demyelination syndrome (ODS) is highest when hyponatremia is corrected too rapidly. Safe correction rate is 8–10 mEq/L per 24 hours. In chronic asymptomatic hyponatremia, even slower correction (4–6 mEq/L per 24 hours) is preferred. ## Why Fluid Restriction is First-Line for Chronic Asymptomatic SIADH 1. **Mechanism**: SIADH is caused by ADH-mediated water reabsorption in collecting ducts. Fluid restriction reduces free water intake, allowing serum sodium to gradually normalize. 2. **Safety**: Gradual correction (over days to weeks) avoids osmotic demyelination. 3. **Efficacy**: In SCLC-related SIADH, fluid restriction is effective in 50–60% of patients. 4. **No risk of overcorrection**: Unlike hypertonic saline, fluid restriction cannot cause rapid sodium rise. **Mnemonic: "FLUID FIRST" for asymptomatic SIADH:** - **F**luid restriction (500–800 mL/day) - **L**ow sodium diet (optional adjunct) - **U**rinalysis and osmolality monitoring - **I**nitiate only if symptomatic → hypertonic saline - **D**emeclocycline reserved for refractory cases ## Why Other Options Are Incorrect **Hypertonic saline** is reserved for symptomatic hyponatremia (seizures, altered mental status, coma). This patient is only mildly symptomatic (lethargy, anorexia) with chronic onset — rapid correction risks ODS. **Normal saline + loop diuretic** is used in euvolemic hyponatremia only if SIADH does not respond to fluid restriction or if hypertonic saline is needed but unavailable. It is not first-line. **Demeclocycline** (ADH antagonist) is reserved for SIADH refractory to fluid restriction, chronic symptomatic hyponatremia requiring long-term management, or when fluid restriction is not tolerated. It has a delayed onset (3–5 days) and is not appropriate for acute management.